A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

April 4, 2019

Study Completion Date

April 4, 2019

Conditions
Type2 Diabetes
Interventions
DRUG

DA-1229_01(A), Sugamet SR Tab 5/1000mg®

"Period 1: Single oral administration of 1 tablet of test drug together with 150 mL of water containing 30 g sugar.~The wash-out for fed study is 14 days. Period 2: Single oral administration of 1 tablet of reference drug together with 150 mL of water containing 30 g sugar."

DRUG

Sugamet SR Tab 5/1000mg®, DA-1229_01(A)

"Period 1: Single oral administration of 1 tablet of reference drug together with 150 mL of water containing 30 g sugar.~The wash-out for fed study is 14 days. Period 2: Single oral administration of 1 tablet of test drug together with 150 mL of water containing 30 g sugar."

Trial Locations (1)

14096

Metro Hospital, Anyang-si

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT03939143 - A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State | Biotech Hunter | Biotech Hunter